Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01238549 · ClinicalTrials.gov registry record

Extending Veteran Participation in the Validation of the SCI-QOL/CAT

A clinical trial of Spinal Cord Injuries, sponsored by VA Office of Research and Development.

Completed
Registry status
284
Enrollment target
2
Study locations

NCT01238549: Completed study of Spinal Cord Injuries, sponsored by VA Office of Research and Development.

NCT01238549 is a study of Spinal Cord Injuries that has completed, run by VA Office of Research and Development. The registered enrollment target is 284 participants, above the 60-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (373% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01238549, a study of Spinal Cord Injuries, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
284 participants
Enrollment target
2
Study locations

Study Summary

The field of spinal cord injury rehabilitation medicine lacks a reliable, patient reported, health-related quality of life measurement tool. The National Institute of Health has provided funding to develop a spinal cord injury-specific, quality of life survey tool in non-Veterans with spinal cord injury called the spinal cord injury-quality of life (SCI-QOL). This quality of life survey asks questions regarding physical/medical, emotional, and social health as it relates to individuals with spinal cord injury. The purpose of this study is to include a Veteran population in the making of the quality of life survey. Each participant will be asked to complete a packet of quality of life questions. Participants will be given the opportunity to take the survey a second time, either 7-14 days or 5-7 months after the first survey. Taking the survey twice will allow the research team to test the reliability of the survey. Comparing the SCI-QOL with other legacy measures will allow the investigators to test the validity of the survey. Additionally, the investigators will be testing the SCI-QOL between Veterans and non-Veterans with SCI to determine if there are differences in their self-reported quality of life. This study will be recruiting participants at the James J. Peters Veterans Affairs Medical Center, Bronx, New York and the James A. Haley Veterans Affairs Hospital, Tampa, Florida.

Primary Outcome

Average score on a questionnaire about level of independence. The minimum score on the scale is 24.6 and the maximum is 68.9. Fifty is the average score. Values below 50 indicate a worse outcome. Values above 50 represent a better outcome.

Conditions Studied

Study Locations (2)

Florida

  • James A. Haley Veterans' Hospital - Tampa

New York

  • James J. Peters VA Medical Center - The Bronx

Trial Details

FieldValue
Enrollment Target 284 participants
Start Date 2012-05-01
Est. Completion 2016-12-31
VA Office of Research and Development

1,668 total trials

What the finished NCT01238549 record still lists

NCT01238549 is an observational study that tracks outcomes without assigning an intervention. The registered 284 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (373% higher).

The record links to 1 condition, with Spinal Cord Injuries appearing as the primary indexed condition, and to 0 interventions.

NCT01238549 reports a single indexed study location in Florida, New York.

Frequently Asked Questions

What is clinical trial NCT01238549 about?

NCT01238549 is a clinical study titled "Extending Veteran Participation in the Validation of the SCI-QOL/CAT". The field of spinal cord injury rehabilitation medicine lacks a reliable, patient reported, health-related quality of life measurement tool. The National Institute of Health has provided funding to develop a spinal cord injury-specific, quality of life survey tool in non-Veterans with spinal cord in...

What is the current status of trial NCT01238549?

This trial is currently completed. The enrollment target is 284 participants. The study started on 2012-05-01. Estimated completion is 2016-12-31.

What conditions does trial NCT01238549 study?

This clinical trial studies the following conditions: Spinal Cord Injuries.

Who is sponsoring clinical trial NCT01238549?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01238549 being conducted?

This trial has 2 study locations across Florida, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01238549's enrollment target sits among peer trials

284 5th of 202 higher than 198 of 202 other Spinal Cord Injuries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05263206 · 284 participants · Phase 3

    Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

  • NCT05769218 · 284 participants · NA

    PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study

  • NCT06856577 · 284 participants · Phase 3

    Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration

  • NCT06963034 · 284 participants · Phase 3

    NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT01238549, the US trial registry maintained by the National Library of Medicine. NCT01238549 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.